FDA Issues 15 Warning Letters.
FDA warns 15 companies for illegally selling various products containing cannabidiol as agency details safety concerns
Violations include marketing unapproved new human and animal drugs, selling CBD products...
Former FDA Head Scott Gottlieb Tells a Worrisome Tale About CBD (MF)
CBD Is Not Safe, Says Former FDA Chief Scott Gottlieb (MotleyFool).
You see, while hemp-based CBD may have been given a pretty clear sales pathway across the country...
“Canopy (CGC) Isn’t Just Selling bad Weed. It’s Setting new Standards for Badness.”
Canopy Growth (WEED.T) financials are catastrophic, $374m loss, $32m in returned product/writedowns (Equity.Guru)
Listen up, true believers – Canopy Growth Corp (WEED.T) will not be rewarding your love any time...
Hiccups at GenCanna?
Or does someone need to perform the Heimlich maneuver!
Lawsuits, delays and an explosion: Troubles mount for Kentucky hemp pioneer GenCanna (HempDailyBiz)
A Kentucky...
Phytophthora ate 40,000 of my Marijuana Plants in Just Two Days!
Clone wars: how tissue culture became the cannabis industry’s unsung protector (Equity.Guru)
Segra International specializes in a form of TC known as micropropagation–a technique some describe as highly-sophisticated cloning–as...
Toxic Marijuana Financings, Shortsellers & Bears, Oh My!
As we near completion of our selections for the Marijuana Bounce Portfolio - Top 20 Marijuana Stocks for 2020 - to take advantage of the Marijuana Index falling from 350 to 130,...
Okay, Maybe I Don’t Want to Be a Hemp Farmer!
Harvesting and Processing may be Expensive Lessons for this Year’s new Hemp Farmers (HarvestIndustryDaily).
Congress legalized hemp to bring a new crop to farmers hurting from depressed markets,...
Vampire Deer Destroy $24 Million Worth of Marijuana.
And Boy Did They Have a Good Time.
Aside from trading commodities, we've made money in every way imaginable including risk arbitrage, flipping closed-end funds and even...
Good Lord. $4 Billion in Potential Good Will Write Downs Coming?
The $4 billion time bomb ticking away inside the biggest marijuana companies (MarketWatch)
Costly early cannabis acquisitions may weigh on future earnings as impairment charges
